In surveys conducted for the STM Association in 2014 and 2020, hundreds of early-career staff working in scholarly publishing disclosed surprising details about their career ambitions and the barriers they face to realize them.
Read about three common themes coming out of recent in-person and virtual publisher interactions, as well as our own data analysis, that could prove useful to the broader scholarly community.
It takes more than having a good idea to find a drug, so the more time a drug discoverer can save in comprehensively identifying all the relevant information, evidence and data, the better.
President and CEO Tracey Armstrong was interviewed about the impact AI is having on CCC and what changes/opportunities we’ll see in research infrastructure over the next 5-10 years, among other timely industry topics.
Carl Robinsons discusses some of the key issues data science teams encounter when building their own datasets, and how a vendor like CCC can help eliminate these issues.
Using publicly available data for research or projects may be attractive because it can be more easily accessible than proprietary or private materials.
